Evidence map›Paper›PMID 28766245›Full record

ArticleDigestive diseases and sciences2017

Elevated Expression of RPA3 Is Involved in Gastric Cancer Tumorigenesis and Associated with Poor Patient Survival.

Zhongming Dai, Shufang Wang, Weiping Zhang, Yunsheng Yang

Abstract read
PubMed Publisher
In one paragraph

Article in Digestive diseases and sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Identification ofBiomedicines · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Rtt105 promotes high-fidelity DNA replication and repair by regulating the single-stranded DNA-binding factor RPA.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Roles of OB-Fold Proteins in Replication Stress.Frontiers in cell and developmental biology · 2020
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Zhongming DaiDepartment of Digestive Disease, PLA General Hospital, Beijing, 100853, People's Republic of China.
Shufang WangDepartment of Digestive Disease, PLA General Hospital, Beijing, 100853, People's Republic of China.
Weiping ZhangDepartment of Digestive Disease, Suzhou BenQ Hospital, Suzhou, 215000, Jiangsu Province, People's Republic of China.
Yunsheng YangDepartment of Digestive Disease, PLA General Hospital, Beijing, 100853, People's Republic of China. yangyunsheng321@163.com.
Chinese PLA General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe replication protein A3 (RPA3) is a component of the RPA protein complex, which plays an essential role in multiple processes of DNA metabolism.

aimsHowever, the involvement of RPA3 in gastric cancer tumorigenesis has not yet been investigated.

methodsWe stably knocked down RPA3 expression using short hairpin RNA in AGS cell line, and performed cell growth, colony formation and soft agar assays. Xenograft experiments were performed to examine tumor promoting properties of RPA3 in vivo. The qRT-PCR and immunohistochemistry were performed to evaluate RPA3 expression levels in 37 and 12 pairs of gastric cancer patient samples, respectively. Association between RPA3 expression and survival was evaluated in an independent cohort of 85 gastric cancer patients.

resultsDownregulation of RPA3 inhibited cell growth, clonogenicity and soft agar growth in AGS cells. Decreased expression of RPA3 significantly reduced tumor growth rate in AGS xenografts. In addition, RPA3 was upregulated in cancerous tissues compared with matched noncancerous adjacent tissues in gastric cancer patients. High expression of RPA3 was associated with poor patient survival.

conclusionUpregulation of RPA3 is involved in gastric cancer tumorigenesis and is associated with poorer patient survival. RPA3 represents a new therapeutic target of gastric cancer and serves as a potential prognostic biomarker for patient survival in gastric cancer.

Indexed as

Gene Expression Regulation, NeoplasticAdultAgedAnimalsBiomarkers, TumorCarcinogenesisDNA-Binding ProteinsFemaleHumansMaleMiceMice, NudeMiddle AgedStomach NeoplasmsSurvival RateXenograft Model Antitumor AssaysBiomarkers, TumorDNA-Binding ProteinsRPA3 protein, humanGastric cancerPoor survivalPrognostic biomarkerRPA3Tumor progression

Identifiers

PMID28766245
OpenAlexW2740284722

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.